The recent challenges in global distribution have highlighted the importance of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes regions to considerable vulnerabilities, including delivery delays, cost fluctuations, and even trade threats. Shifting towards domestic procurement of Ivermectin offers a multitud